Luca Andriolo1, Giulia Merli2, Carlos Tobar3, Sante Alessandro Altamura1, Elizaveta Kon4,5, Giuseppe Filardo6. 1. II Orthopaedic and Traumatologic Clinic, Rizzoli Orthopaedic Institute, Bologna, Italy. 2. Nano-Biotechnology Laboratory-NaBi, Research and Innovation Technology Department, Bologna, Italy. giuliamerli85@gmail.com. 3. Department of Orthopedics and Traumatology, Avansalud Clinic of Santiago, Santiago, Chile. 4. Humanitas University Department of Biomedical Sciences, Milan, Italy. 5. Humanitas Clinical and Research Center, Milan, Italy. 6. Nano-Biotechnology Laboratory-NaBi, Research and Innovation Technology Department, Bologna, Italy.
Abstract
PURPOSE: The aim of this study was to document the available evidence on the use of regenerative techniques for the treatment of femoral head osteonecrosis (or avascular necrosis of femoral head, AVN) and to understand their benefit compared to core decompression (CD) alone in avoiding failure and the need for total hip replacement (THR). METHODS: The search was conducted on three medical electronic databases according to PRISMA guidelines. The studies reporting number and timing of failures were included in a meta-analysis calculating cumulative survivorship with a Kaplan-Mayer curve. Moreover, the results on failures in treatment groups reported in RCT were compared with those documented in control groups, in order to understand the benefit of biological therapies compared to CD for the treatment of AVN. RESULTS: Forty-eight studies were included in this systematic review, reporting results of different types of regenerative techniques: mesenchymal stem cell implantation in the osteonecrotic area, intra-arterial infiltration with mesenchymal stem cells, implantation of bioactive molecules, or platelet-rich plasma. Overall, reported results were good, with a cumulative survivorship of 80% after ten year follow-up, and better results when regenerative treatments were combined to CD compared to CD alone (89.9% vs 70.6%, p < 0.0001). CONCLUSION: Regenerative therapies offer good clinical results for the treatment of AVN. The combination of CD with regenerative techniques provides a significant improvement in terms of survivorship over time compared with CD alone. Further studies are needed to identify the best procedure and the most suitable patients to benefit from regenerative treatments for AVN.
PURPOSE: The aim of this study was to document the available evidence on the use of regenerative techniques for the treatment of femoral head osteonecrosis (or avascular necrosis of femoral head, AVN) and to understand their benefit compared to core decompression (CD) alone in avoiding failure and the need for total hip replacement (THR). METHODS: The search was conducted on three medical electronic databases according to PRISMA guidelines. The studies reporting number and timing of failures were included in a meta-analysis calculating cumulative survivorship with a Kaplan-Mayer curve. Moreover, the results on failures in treatment groups reported in RCT were compared with those documented in control groups, in order to understand the benefit of biological therapies compared to CD for the treatment of AVN. RESULTS: Forty-eight studies were included in this systematic review, reporting results of different types of regenerative techniques: mesenchymal stem cell implantation in the osteonecrotic area, intra-arterial infiltration with mesenchymal stem cells, implantation of bioactive molecules, or platelet-rich plasma. Overall, reported results were good, with a cumulative survivorship of 80% after ten year follow-up, and better results when regenerative treatments were combined to CD compared to CD alone (89.9% vs 70.6%, p < 0.0001). CONCLUSION: Regenerative therapies offer good clinical results for the treatment of AVN. The combination of CD with regenerative techniques provides a significant improvement in terms of survivorship over time compared with CD alone. Further studies are needed to identify the best procedure and the most suitable patients to benefit from regenerative treatments for AVN.
Authors: Nicolas S Piuzzi; Jorge Chahla; Hao Jiandong; Morad Chughtai; Robert F LaPrade; Michael A Mont; George F Muschler; Cecilia Pascual-Garrido Journal: J Arthroplasty Date: 2017-03-15 Impact factor: 4.757
Authors: Thorsten M Seyler; David R Marker; Slif D Ulrich; Tobias Fatscher; Michael A Mont Journal: Clin Orthop Relat Res Date: 2008-05 Impact factor: 4.176
Authors: Philippe Hernigou; Benjamin Thiebaut; Victor Housset; Claire Bastard; Yasuhiro Homma; Younes Chaib; Charles Henri Flouzat Lachaniette Journal: Int Orthop Date: 2018-04-26 Impact factor: 3.075
Authors: Philippe Hernigou; Guillaume Rigoulot; Jean Charles Auregan; Victor Housset; Claire Bastard; Arnaud Dubory; Charles Henri Flouzat Lachaniette Journal: SICOT J Date: 2018-11-05